Aratana Therapeutics to Showcase Extensive Clinical Development Pipeline at ACVIM

Aratana Therapeutics, Inc.

, a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, today announced that data and observational studies resulting from the Company's extensive clinical development pipeline will be featured in multiple oral and poster presentations during the 2015 American College of Veterinary Internal Medicine Forum (ACVIM) in Indianapolis, IN. The 2015 ACVIM Forum is being held June 3-6, 2015 at the Indiana Convention Center to advance the growth and science of veterinary and animal care. Showcasing its growing leadership in the development and commercialization of pet medications, Aratana's advancements in the treatment of pet oncology, inappetence and pain will be the subject of 11 presentations during the 2015 ACVIM Forum. The presentations will be given by veterinary industry experts over the course of the four-day conference: Cancer Therapies and Clinical Studies Title: The Evolving Science of Immunotherapeutics in Veterinary Oncology Date: Thursday, June 4, 2015 Time/Type: 10:30 am – 11:20 am (Eastern Time) – CE Presentation Location: Indiana Convention Center – Sagamore 7 Presenter: Philip J. Bergman, DVM, Ph.D., DACVIM (Oncology); and Chad Johannes, DVM, DACVIM (SAIM, Oncology) Title: A Prospective, Open-Label Study Evaluating Treatment of Canine B-cell Lymphoma with L-Asparaginase, Doxorubicin and a Canine Anti-CD20 Monoclonal Antibody Date: Thursday, June 4, 2015 Time/Type: 11:00 am – 11:15 am (Eastern Time) – Abstract Presentation Location: Indiana Convention Center – Room 233 Presenter: Carlos O. Rodriguez, Jr., DVM, Ph.D., DACVIM (Oncology) Title: Clinical Application of Immunotherapeutics in Veterinary Oncology Date: Thursday, June 4, 2015 Time/Type: 11:30 am – 12:20 pm (Eastern Time) – CE Presentation Location: Indiana Convention Center – Sagamore 7 Presenter: Philip J. Bergman, DVM, Ph.D., DACVIM (Oncology); and Chad Johannes, DVM, DACVIM (SAIM, Oncology) Title: Anti-CD20 Monoclonal Antibody Canine Lymphoma Therapy: A Double-Blind, Randomized, Placebo-Controlled Study Date: Friday, June 5, 2015 Time/Type: 5:25 pm – 5:50 pm (Eastern Time) – Research Report Presentation Location: Indiana Convention Center – Room 201 Presenter: Gregory Ogilvie, DACVIM (SAIM, Oncology), DECVIM-CA (Oncology) Title: Combination Listeria-Based Immunotherapy Plus Palliative Radiation Delays Tumor Progression and Prolongs Overall Survival in Canine Osteosarcoma Date: Saturday, June 6, 2015 Time/Type: 8:00 am (Eastern Time) – Late-Breaking Abstract Presentation Location: Indiana Convention Center – Room 204 Presenter: Nicola Mason, BVetMed, Ph.D., DACVIM (SAIM) Inappetence Solutions in Development Title: Safety of the Ghrelin Agonist, Capromorelin, Administered Daily to Beagle Dogs for One Year Date: Thursday, June 4, 2015 Time/Type: 10:30 am – 10:45 am (Eastern Time) – Abstract Presentation Location: Indiana Convention Center – Room 231 Presenter: Linda Rhodes, VMD, Ph.D. Title: Capromorelin, An Orally Active Ghrelin Agonist, Caused Sustained Increases in IGF-1, Increased Food Intake and Body Weight in Cats Date: Friday, June 5, 2015 Time/Type: 6:00 pm – 7:30 pm (Eastern Time) – Abstract Poster Session Location: Indiana Convention Center – Hall C Presenter: Bill Zollers, Ph.D. Title: Safety of the Ghrelin Agonist, Capromorelin, Administered to Cats for 91 Days at an Oral Dose of 6 mg/kg Date: Friday, June 5, 2015 Time/Type: 6:00 pm – 7:30 pm (Eastern Time) – Abstract Poster Session Location: Indiana Convention Center – Hall C Presenter: Julie Allen, BVMS, MS, MRCVS, DACVIM (SAIM) Title: New Therapeutic Advances in Inappetence for Pets Date: Friday, June 5, 2015 Time/Type: 6:30 am – 8:00 am (Eastern Time) – Special Breakfast Session Location: Indiana Convention Center – Room 123-124 Presenter: Audrey Cook, BVM&S, MRCVS, DACVIM, (SAIM), DECVIM (CA), DABVP (Feline); and Julie Allen, BVMS, MS, MRCVS, DACVIM (SAIM) Pain Management Treatment Advances Title: Introduction to the Emerging Piprant Therapeutic Class of Prostanoid Receptor Antagonists Date: Friday, June 5, 2015 Time/Type: 9:00 am – 9:50 am (Eastern Time) – CE Presentation Location: Indiana Convention Center – Sagamore 1 Presenter: Kristin Kirkby Shaw, DVM, MS, Ph.D., DACVS, DACVSMR Title: Safety and Toxicokinetic Profiles in Cats Administered Grapiprant, A Selective Prostaglandin-Receptor Antagonist Date: Friday, June 5, 2015 Time/Type: 6:00 pm – 7:30 pm (Eastern Time) – Abstract Poster Session Location: Indiana Convention Center – Hall C Presenter: Lesley Rausch-Derra, DVM, MS